U.K. Budget May Keep Pressure on Assets Before Oct. 28
Investors await John Healey’s assurances on fiscal sustainability as 10-year gilt yields remain above 5.4%.
GBP/USDU.K. gilts10-year gilt yield
market news: macro
central bank decisions, rates, inflation and data releases, explained through their market impact.
stories appear here with a 15-minute delay. in real time — via the api connect the api →
Citizens Raises Price Targets for Slide Insurance and Ethos Technologies
Citizens kept a Market Outperform rating on both companies and lifted its target for Slide Insurance to $28 and Ethos Technologies to $40.
SLDELIFE
Swedish Krona May Gain as Geopolitical Tensions Ease
ING sees modest upside for the Swedish krona if French fiscal risks continue to weigh on the euro for longer.
EUR/SEKSwedish kronaEuro
Needham reaffirms Buy rating on Harmony Biosciences, $50 target
Needham maintained its Buy rating and $50 price target for Harmony Biosciences, implying 24.1% upside from the stock’s Oct. 9 close.
Harmony Biosciences Hldgs
Frasers lifts Burberry stake to 7.42% as luxury push continues
British retailer Frasers has increased its Burberry holding again while expanding its strategy and interests in the luxury sector.
BurberryFrasersHugo Boss
Citizens Lowers Price Targets for Stewart and Brown & Brown
Citizens cut its price targets for Stewart Info Services and Brown & Brown, while keeping Brown & Brown at Market Outperform.
STCBRO
High oil prices and strong fundamentals support Norwegian krone
ING says the Norwegian krone may strengthen further as elevated oil prices and supportive fundamentals outweigh weaker liquidity conditions.
Norwegian kroneEUR/NOKBrent
Xi’s ambitions deepen China’s debt burden and trade pressure abroad
Dow Jones Newswires, citing the WSJ, reports that China’s nonfinancial-sector credit exceeded 300% of GDP as debt-fueled overcapacity spread overseas.
CNYChinese equitiesChina government bondsEUR/USDBrent
Deutsche Bank upgrades AST SpaceMobile stock to Buy
Deutsche Bank analyst Bryan Kraft called AST SpaceMobile’s recent decline misguided and raised the stock rating to Buy, keeping the target at $93.
AST SpaceMobileSpaceXRocket LabT-MobileAT&TS&P 500
Starbucks Denies Reports That It Plans to Buy Chipotle
Starbucks said it will not acquire Chipotle after reports that the burrito chain had discussed a possible proposal with advisers.
StarbucksChipotle Mexican Grill
Italy’s advertising spending rose 1% year on year in August
Nielsen reported that advertising spending in Italy increased 1% year on year in August, Reuters said.
Microsoft plans to introduce Maia 300 AI chip in 2027
Microsoft says its next AI accelerator will target inference, boosting token throughput and power efficiency across the company’s cloud-scale systems.
MicrosoftTaiwan Semiconductor Manufacturing CoNvidia
Schroder Euro Real sets sterling dividend at 1.24986 pence
London Stock Exchange said Schroder European Real Estate Investment Trust will pay UK-register holders 1.24986 pence per share in sterling.
Schroder European Real Estate Investment Trust plcGBPEURJSE Limited
UBS Initiates Ocular Therapeutix Coverage With Buy Rating
UBS began covering Ocular Therapeutix with a Buy rating and set a $14.00 per-share price target for the company’s stock.
OCUL
Guggenheim Raises Elevance Health Price Target to $460
Guggenheim increased its price target for Elevance Health to $460 per share from $455, according to ratings data from Benzinga.
ELVElevance Health
Guggenheim Maintains Buy Rating on Everpure
Guggenheim kept its Buy rating on Everpure, according to Benzinga’s summary of analyst rating actions.
Everpure
KBW Keeps Outperform Ratings on Chubb and Goosehead
Keefe, Bruyette & Woods maintained its Outperform rating on Chubb Ltd and Goosehead Insurance, according to analyst actions published by Benzinga.
CBGSHD
UBS Starts AbCellera Biologics Coverage With Buy Rating
UBS began covering AbCellera Biologics with a Buy rating and set a target price of $18.00 per share, according to a Benzinga ratings update.
ABCLAbCellera Biologics
HCLTech says lower software sales weighed on second-quarter growth
HCLTech said weaker software product sales affected second-quarter growth, while demand remained healthy toward the quarter’s end amid a fluid environment.
HCLTech
HCLTech expects data-centre projects to add revenue from H2 FY28
HCLTech remains cautious on its outlook amid a volatile environment and expects revenue to gradually decouple from headcount as more IP is embedded.
HCLTechHCLTECH